Compare Humana Inc (HUM) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs VanEck Rare Earth/Strategic Metals — how do they compare? Humana Inc trades at $403.59 (market cap $47.81B), while VanEck Rare Earth/Strategic Metals trades at $71.27. The key difference: Humana Inc pays a 0.89% dividend while VanEck Rare Earth/Strategic Metals pays none, and Humana Inc is trading nearer its 52-week high, VanEck Rare Earth/Strategic Metals nearer its low. Which is the better fit depends on your goals.
| HUM | REMX | |
|---|---|---|
Market Cap | $47.81B | — |
Sector | Health | Sector/Thematic |
52-Week High | $409.42 | $109.53 |
52-Week Low | $163.67 | $49.22 |
Enterprise Value | $56.85B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
REMX (VanEck Rare Earth and Strategic Metals ETF) trades at $69.85, down 3.88% over the past day amid a bearish technical signal, with moving averages indicating strong selling pressure. The ETF provides exposure to 38 global rare earth and strategic metals companies, heavily weighted toward China, and exhibits high volatility around 50% annually. Recent news highlights rare earth metals' strategic importance in technology and energy security, with China's export controls and geopolitical tensions influencing supply dynamics.
Outlook remains speculative due to geopolitical risks and commodity price swings, offering growth potential from the reshoring of critical mineral supply chains. Key risks include China concentration, regulatory changes, and high ETF turnover, making it suitable only for aggressive portfolios as a satellite holding. Investors should weigh supply chain diversification trends against volatility and liquidity concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About VanEck Rare Earth/Strategic Metals
REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →
